Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Abbott Reports Fourth-Quarter and Full-Year 2024 Results Issues 2025 Financial Outlook

January 28, 2025
Abbott Laboratories, a global healthcare company, recently announced its financial results for the fourth quarter and full year of 2024. The company reported strong performance across its various business segments, including medical devices, diagnostics, nutrition, and established pharmaceuticals.

For the fourth quarter of 2024, Abbott Laboratories reported a revenue of $13.5 billion, representing a 10% increase compared to the same period last year. The company's earnings per share (EPS) for the quarter stood at $0.98, exceeding analysts' expectations.

In the full year of 2024, Abbott Laboratories recorded a total revenue of $52.3 billion, a 9.5% growth from the previous year. The company's EPS for the full year reached $3.76, reflecting a significant improvement compared to 2023.

Based on its strong performance in 2024, Abbott Laboratories also provided its financial outlook for 2025. The company expects to continue its growth momentum, projecting a revenue growth of 8-10% for the year.

Abbott Laboratories has been consistently delivering solid financial results and has a positive outlook for the future. Investors and analysts are optimistic about the company's prospects, with many expecting it to post impressive earnings in the coming months.

To gain further insights into the movement of Abbott Laboratories' stocks, investors are recommended to consult professionals from Stocks Prognosis. With their expertise in stock market analysis, Stocks Prognosis can offer valuable forecasts and guidance to investors looking to maximize their returns in the pharmaceuticals sector.
If you want to leave a comment, then you need Login or Register





Other data for ABT

Related data

ABTAugust 9, 2025Abbott Laboratories NYSE:ABT Earnings Are Of Questionable Quality  ~1 min.

Abbott Laboratories recently reported their second quarter 2025 earnings, with EPS exceeding expectations....


ABTJune 5, 2025Abbott Laboratories ABT is Attracting Investor Attention: Here is What You Should Know  ~1 min.

Abbott Laboratories (ABT) has been making waves in the healthcare sector, attracting attention from investors around the globe....


ABTMarch 18, 2025Abbott Laboratories Continues to Drive Growth in the Healthcare Sector  ~2 min.

Abbott Laboratories (ABT) has emerged as a top player in the healthcare industry, making it an attractive stock for long-term investors....


ABTMarch 17, 2025Abbott Laboratories: A Leader in Healthcare Innovation  ~2 min.

Abbott Laboratories (NYSE: ABT) is a renowned healthcare company that has caught the attention of investors and industry experts alike....


ABTMarch 16, 2025Abbott Laboratories: Breaking New Ground in Healthcare Innovation  ~2 min.

Abbott Laboratories (NYSE: ABT) has been making waves in the healthcare industry with its groundbreaking innovations....


ABTMarch 15, 2025Abbott Laboratories: A Healthcare Stock With Long-Term Investment Potential  ~2 min.

Abbott Laboratories (NYSE:ABT) is a renowned healthcare company that has been delivering groundbreaking medical technologies and products for decades....


ABTFebruary 26, 2025Abbott Laboratories Continues to Deliver Strong Earnings Growth  ~2 min.

Abbott Laboratories, a leading global healthcare company, has reported steady growth in earnings over the past five years....


ABTFebruary 22, 2025Abbott Laboratories: A Rising Star in the Pharmaceutical Industry  ~2 min.

Abbott Laboratories (NYSE: ABT) has been making significant progress in the pharmaceutical industry, positioning itself as one of the best drug stocks to buy now....


ABTFebruary 21, 2025Abbott Laboratories NYSE:ABT: A Leading Drug Stock with Promising Future  ~1 min.

Abbott Laboratories, a renowned pharmaceutical company, has emerged as one of the best drug stocks to invest in....


ABTFebruary 21, 2025ABBOTT LABORATORIES Stock Hits Price Target with 16.11% Profit: QuantWave Forecast Success  ~2 min.

On December 2, 2024, QuantWave, the automated forecasting platform, issued a long signal for ABBOTT LABORATORIES stock when it was trading at 115.66 $....


ABTJanuary 2, 2025Abbott Laboratories' Fundamental Strengths Signal Future Market Correction: Stocks Prognosis  ~1 min.

Abbott Laboratories, a global healthcare company, has lately witnessed a decline in its stock performance....


ABTJanuary 11, 2025Abbott Laboratories: A Leading Healthcare Company with Promising Future  ~2 min.

Abbott Laboratories (NYSE:ABT) is a renowned global healthcare company that continues to make significant contributions in the field of medical technology and pharmaceuticals....


ABTMarch 17, 2025Abbott Laboratories: A Leader in Healthcare Innovation  ~2 min.

Abbott Laboratories (NYSE: ABT) is a renowned healthcare company that has caught the attention of investors and industry experts alike....


ABTJanuary 24, 2025ABBOTT LABORATORIES Hits Price Target Forecast with 10.16% Profit  ~1 min.

Abbott Laboratories' stock successfully reached the price target forecast set by QuantWave on January 24, 2025. The forecast, issued on October 8, 2024, indicated a long position at a price of $112....


ABTDecember 13, 2024Abbott Laboratories Continues to Impress Investors with Solid Dividends and Growth  ~2 min.

Abbott Laboratories (NYSE: ABT) has emerged as one of the best Dividend Kings in the market, offering safe dividend growth for long-term investors....